Viewing Study NCT00310518


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2025-12-26 @ 4:05 AM
Study NCT ID: NCT00310518
Status: COMPLETED
Last Update Posted: 2009-04-29
First Post: 2006-03-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of ARQ 501 in Adult Patients With Leiomyosarcoma
Sponsor: ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module